Junwen Zhou
BSc, MSc, PhD
Senior Researcher
Junwen Zhou joined the Health Economics Research Centre (HERC) in October 2020 as Senior Researcher. His work focusses on economic analysis and modelling of chronic diseases using individual participant data from large randomised controlled trials and observational data with focus on cardiovascular disease prevention.
Junwen is experienced in health economic evaluation methods and applications. Prior to his current position, he worked as Modelling Lead in Global Health Economic and Value Assessment (HEVA) in Sanofi, France. Before that, he worked as Research Analyst, then Senior Analyst in Health Economic and Outcome Research (HEOR) in Creativ-Ceutical, France. He also has clinical experience, worked as Clinical Pharmacist Intern in Peking University Third Hospital, China.
Junwen received his PhD in Clinical Research and Public Health from Aix-Marseille University, France, with thesis focusing on economic modelling with discrete event simulation (DES) in schizophrenia. He received his MSc in Clinical Pharmacy from Peking University, China, with thesis focusing on evidence synthesis with network meta-analysis (NMA) in osteoporosis. He received his BSc in Pharmacy with dual degree in Economics from Peking University, China.
Recent publications
-
Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.
Zhou J. et al, (2024), Br J Psychiatry, 1 - 8
-
Medication adherence and costs of medical care among patients with Parkinson's disease: an observational study using electronic medical records.
Yi Z. et al, (2024), BMC Public Health, 24
-
Estimating Costs Associated with Disease Model States Using Generalized Linear Models: A Tutorial.
Zhou J. et al, (2024), Pharmacoeconomics, 42, 261 - 273
-
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
MIHAYLOVA B. et al, (2024), The Lancet Regional Health - Europe
-
Long-term cardiovascular risks and statin treatment impact on socioeconomic inequalities: microsimulation model
Wu R. et al, (2023), British Journal of General Practice